Home  »  Companies   »  Evaluating the Impact of -6.58 Increase on Protali...

Evaluating the Impact of -6.58 Increase on Protalix BioTherapeutics Inc.’s (PLX) Stock

The stock of Protalix BioTherapeutics Inc. (PLX) has seen a -0.47% decrease in the past week, with a -21.11% drop in the past month, and a 17.03% flourish in the past quarter. The volatility ratio for the week is 7.03%, and the volatility levels for the past 30 days are at 11.55% for PLX. The simple moving average for the past 20 days is -18.16% for PLX’s stock, with a 36.16% simple moving average for the past 200 days.

Is It Worth Investing in Protalix BioTherapeutics Inc. (AMEX: PLX) Right Now?

and a 36-month beta value of 1.46.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


The public float for PLX is 41.75M, and at present, short sellers hold a 19.47% of that float. On May 25, 2023, the average trading volume of PLX was 2.17M shares.

PLX) stock’s latest price update

The stock of Protalix BioTherapeutics Inc. (AMEX: PLX) has decreased by -6.58 when compared to last closing price of 2.28.Despite this, the company has seen a loss of -0.47% in its stock price over the last five trading days.

PLX Trading at -10.29% from the 50-Day Moving Average

After a stumble in the market that brought PLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.00% of loss for the given period.

Volatility was left at 11.55%, however, over the last 30 days, the volatility rate increased by 7.03%, as shares sank -18.91% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.65% upper at present.

During the last 5 trading sessions, PLX rose by +1.17%, which changed the moving average for the period of 200-days by +83.47% in comparison to the 20-day moving average, which settled at $2.58. In addition, Protalix BioTherapeutics Inc. saw 55.47% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at PLX starting from Schwartz Aharon, who purchase 110,000 shares at the price of $1.42 back on Jan 03. After this action, Schwartz Aharon now owns 174,000 shares of Protalix BioTherapeutics Inc., valued at $155,815 using the latest closing price.

Stock Fundamentals for PLX

Current profitability levels for the company are sitting at:

  • -27.32 for the present operating margin
  • +58.87 for the gross margin

The net margin for Protalix BioTherapeutics Inc. stands at -31.33. The total capital return value is set at -51.78, while invested capital returns managed to touch -62.27. Equity return is now at value 203.30, with -26.30 for asset returns.

When we switch over and look at the enterprise to sales, we see a ratio of 3.90, with the company’s debt to enterprise value settled at 0.43. The receivables turnover for the company is 11.87 and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.38.


To sum up, Protalix BioTherapeutics Inc. (PLX) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.